LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer
This study is currently recruiting participants.
Verified December 2011 by Massachusetts General Hospital
Sponsor:
Massachusetts General Hospital
Collaborator:
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Eunice L. Kwak, MD, PhD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01485744
First received: December 1, 2011
Last updated: December 20, 2011
Last verified: December 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | September 2013 (Final data collection date for primary outcome measure) |